Whereas Reg-1 was recently reported to negatively regulate IL-23/IL-17 transcript levels at early stages of IMQ-driven experimental psoriasis [30] our data suggest that Reg-3 might also reduce pathogenic inflammation by directly controlling TNF turnover in psoriasis. Here, IL17A is linked to psoriasis.